Sponsored by
Join Geeta Nayyar, MD, MBA in this 4-episode series as she discusses the value of vaccination for health plans and the challenges involved with multiple health professionals who are experts in healthcare economics and vaccine policy.
Children’s vaccination programs have been championed as great public health initiatives. Why have such successes not been replicated in the adult population? This episode explores the impact of adult vaccination, and potential adherence solutions providers and payers can implement.
Children’s vaccination programs have been championed as great public health initiatives. Why have such successes not been replicated in the adult population? This episode explores the impact of adult vaccination, and potential adherence solutions providers and payers can implement.
Featuring Kim Thiboldeaux & Jane Sarasohn-Kahn
Several factors influence a member’s ability to get vaccinated, some of which aren’t in their control. Exploring a theoretical member journey, this episode highlights the factors that may hinder adult vaccination and identifies how health plans and payers can make an impact.
Several factors influence a member’s ability to get vaccinated, some of which aren’t in their control. Exploring a theoretical member journey, this episode highlights the factors that may hinder adult vaccination and identifies how health plans and payers can make an impact.
Featuring Venesa Day, MPA, CPCO & Elif Alyanak, DrPH
Providers have voiced frustration over low reimbursement for vaccines, specifically regarding costs not tied to acquisition. This episode voices those frustrations and uncovers new ways to help expand the dialogue between providers and payers when discussing vaccines and reimbursement.
Providers have voiced frustration over low reimbursement for vaccines, specifically regarding costs not tied to acquisition. This episode voices those frustrations and uncovers new ways to help expand the dialogue between providers and payers when discussing vaccines and reimbursement.
The value of vaccination is facing unprecedented skepticism. What can be done to address misinformation and build trust? How do we address the sometimes polarizing topics of public health? This episode will discuss the strategies that may open the dialogue on the impact of vaccines across the healthcare landscape.
The value of vaccination is facing unprecedented skepticism. What can be done to address misinformation and build trust? How do we address the sometimes polarizing topics of public health? This episode will discuss the strategies that may open the dialogue on the impact of vaccines across the healthcare landscape.
This site is intended for U.S. population health decision makers only. The information provided is for educational purposes only.
Information on this website is directed toward U.S. residents only.
© 2025 Pfizer Inc. All rights reserved.
PP-UNP-USA-7492